LifeMine Therapeutics Competitors and Similar CompaniesClear all
LifeMine Therapeutics's competitors and similar companies include Esteve, Harrow Health, India Globalization Capital and KSQ Therapeutics.
 LifeMine Therapeutics LifeMine Therapeutics is a pharmaceutical company that develops fungi-based therapies. |  Harrow Health Harrow Health (formerly Imprimis Pharmaceuticals) is a pharmaceutical company dedicated to delivering high quality and innovative medicines to physicians and patients at accessible prices. |  India Globalization Capital India Globalization Capital develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States. |  KSQ Therapeutics KSQ Therapeutics develops and deploys precision functional genomics to discover drug therapies. | ||
Founding Date | Founding Date 2017 | Founding Date 1929 | Founding Date 2012 | Founding Date 2005 | Founding Date 2015 |
Type | Type Private | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Cambridge, US HQ Basel, CH Gloucester, US | Locations San Diego, US HQ Cottonwood Heights, US Irvine, US Nashville, US Roxbury Township, US | Locations Bethesda, US HQ | Locations Cambridge, US HQ | |
Employees | Employees 6811% decrease | Employees 2,0063% increase | Employees 1331% decrease | Employees 50150% increase | Employees 871% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.7 b | Valuation ($) 30 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $272.3m (FY, 2025) | Revenue (est.) $869k (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $67.9m (FY, 2025) | Cost of goods $572k (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $204.4m (FY, 2025) | Gross profit $297k (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income N/A | Net income ($5.1m) (FY, 2025) | Net income ($4.1m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 55m (over 8 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 80m (over 7 years ago) |
Total funding raised | Total funding raised $ 55m | Total funding raised N/A | Total funding raised $ 48.7m | Total funding raised N/A | Total funding raised $ 156m |
For sources of this data, please see the company profile
View Company Profiles
Esteve
HQ
Barcelona, ES
Employees
2,006↑ 3% increase
Esteve is a company that manufactures and supplies pharmaceuticals.
View companyHarrow Health
HQ
San Diego, US
Employees
133↓ 1% decrease
Harrow Health (formerly Imprimis Pharmaceuticals) is a pharmaceutical company dedicated to delivering high quality and innovative medicines to physicians and patients at accessible prices.
View companyIndia Globalization Capital
HQ
Bethesda, US
Employees
50
India Globalization Capital develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States.
View companyKSQ Therapeutics
HQ
Cambridge, US
Employees
87↑ 1% increase
KSQ Therapeutics develops and deploys precision functional genomics to discover drug therapies.
View company